Literature DB >> 10696782

Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells.

J S Isenberg1, J E Klaunig.   

Abstract

Rotenone inhibits spontaneously and chemically induced hepatic tumorigenesis in rodents through the induction of apoptosis. However, the mechanism for the induction of apoptosis by rotenone has not been defined. Mitochondrial dysfunction, in particular the induction of the mitochondrial membrane permeability transition (MPT), has been implicated in the cascade of events involved in the induction of apoptosis. Inhibition of the mitochondrial electron-transport chain reduces the mitochondrial transmembrane potential (delta(psi)m), which may induce the formation of the mitochondrial permeability transition pore and the subsequent MPT. Fluorescent microscopy of Hoechst 33258-stained WB-F344 cells, a rat-liver cell line, was utilized to examine the effect of the mitochondrial respiratory chain inhibitor, rotenone (0.5-5 microM), atractyloside (5-10 microM), and cyclosporin A (2.5-10 microM) on apoptosis. A time- and concentration-dependent increase in liver cell apoptosis was observed following treatment with rotenone and atractyloside (11.7- and 7.7-fold, respectively, over solvent control). Cotreatment with 7.5- and 10 microM-cyclosporin A for 12 h inhibited the apoptogenicity of 5-microM rotenone treatment. A similar effect was observed following cyclosporin A cotreatment with atractyloside. Rotenone induced a rapid increase in apoptosis (within 20 min of treatment). By 2 h of treatment, the morphological appearance of apoptosis was similar to that observed in cultures treated continuously with rotenone for 12 h. Inhibition studies demonstrated that cyclosporin A prevented apoptosis if the exposure to it occurred prior to the 20-min threshold necessary to induce apoptosis by rotenone. Mitochondrial function was examined by staining with the mitochondrial membrane potential (delta(psi)m)-sensitive fluorochrome, MitoTracker Red (CMXRos) and confirmed utilizing cytofluorometric analysis of DiOC6(3)-stained cells. Rotenone (5.0-microM) and atractyloside (5.0-microM) reduced the percent of CMXRos or DiOC6(3)-positive (delta(psi)m-positive) liver cells within 15 min and throughout the duration of the study (6 h) to approximately 65-80% and 50-80% of control. However, cotreatment with concentrations of cyclosporin A that inhibited the apoptogenicity of rotenone and atractyloside prevented the rotenone- and atractyloside-induced reduction of the delta(psi)m. Therefore, the apoptogenic effect of rotenone and atractyloside appears to occur rapidly (within 20 min) and is irreversible once mitochondrial damage occurs. The inhibition of the rotenone- and atractyloside-induced apoptosis and mitochondrial dysfunction by cyclosporin A suggests the MPT may be involved in the induction of apoptosis by rotenone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696782     DOI: 10.1093/toxsci/53.2.340

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  52 in total

1.  Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/reperfusion.

Authors:  Qiulin Xu; Xixian Li; Yongkang Lu; Liang Shen; Jingwen Zhang; Shiping Cao; Xiaobo Huang; Jianping Bin; Yulin Liao
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

2.  Differential involvement of mitochondrial permeability transition in cytotoxicity of 1-methyl-4-phenylpyridinium and 6-hydroxydopamine.

Authors:  Chung Soo Lee; Woo Jae Park; Hyun Hee Ko; Eun Sook Han
Journal:  Mol Cell Biochem       Date:  2006-04-20       Impact factor: 3.396

3.  Protective effects of asiatic acid on rotenone- or H2O2-induced injury in SH-SY5Y cells.

Authors:  Yuyun Xiong; Hongqun Ding; Minfang Xu; Jing Gao
Journal:  Neurochem Res       Date:  2008-09-19       Impact factor: 3.996

4.  Depressant effect of mitochondrial respiratory complex inhibitors on proteasome inhibitor-induced mitochondrial dysfunction and cell death in PC12 cells.

Authors:  Sun-Joo Lee; Young Chul Youn; Eun Sook Han; Chung Soo Lee
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

5.  α-Arbutin Protects Against Parkinson's Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo.

Authors:  Yaqi Ding; Deqin Kong; Tong Zhou; Nai-di Yang; Chenqi Xin; Jiajia Xu; Qi Wang; Hang Zhang; Qiong Wu; Xiaomei Lu; Kahleong Lim; Bo Ma; Chengwu Zhang; Lin Li; Wei Huang
Journal:  Neuromolecular Med       Date:  2019-08-10       Impact factor: 3.843

6.  Duloxetine Protects Human Neuroblastoma Cells from Oxidative Stress-Induced Cell Death Through Akt/Nrf-2/HO-1 Pathway.

Authors:  Daiane Fátima Engel; Jade de Oliveira; Vicente Lieberknecht; Ana Lucia Severo Rodrigues; Andreza Fabro de Bem; Nelson Horácio Gabilan
Journal:  Neurochem Res       Date:  2017-11-13       Impact factor: 3.996

7.  Differential involvement of intracellular Ca2+ in 1-methyl-4-phenylpyridinium- or 6-hydroxydopamine-induced cell viability loss in PC12 cells.

Authors:  Dong Hee Lee; Young Su Han; Eun Sook Han; Hyoweon Bang; Chung Soo Lee
Journal:  Neurochem Res       Date:  2006-06-28       Impact factor: 3.996

8.  Proteolytic regulation of the mitochondrial cAMP-dependent protein kinase.

Authors:  Jennifer R Shell; David S Lawrence
Journal:  Biochemistry       Date:  2012-03-08       Impact factor: 3.162

9.  Vitamin K2 suppresses rotenone-induced microglial activation in vitro.

Authors:  Yan-Xia Yu; Yi-Pei Li; Feng Gao; Qing-Song Hu; Yan Zhang; Dong Chen; Guang-Hui Wang
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

10.  Baicalein-induced apoptosis via endoplasmic reticulum stress through elevations of reactive oxygen species and mitochondria dependent pathway in mouse-rat hybrid retina ganglion cells (N18).

Authors:  Yu-Ching Li; Hui-Ju Lin; Jen-Hung Yang; Jai-Sing Yang; Heng-Chien Ho; Shu-Jen Chang; Te-Chun Hsai; Hsu-Feng Lu; An-Cheng Huang; Jing-Gung Chung
Journal:  Neurochem Res       Date:  2008-07-26       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.